PT3564230T - Compostos de guanidina substituídos - Google Patents
Compostos de guanidina substituídosInfo
- Publication number
- PT3564230T PT3564230T PT178861092T PT17886109T PT3564230T PT 3564230 T PT3564230 T PT 3564230T PT 178861092 T PT178861092 T PT 178861092T PT 17886109 T PT17886109 T PT 17886109T PT 3564230 T PT3564230 T PT 3564230T
- Authority
- PT
- Portugal
- Prior art keywords
- guanidine compound
- substituted guanidine
- substituted
- compound
- guanidine
- Prior art date
Links
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 title 1
- ZRALSGWEFCBTJO-UHFFFAOYSA-N anhydrous guanidine Natural products NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 title 1
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 title 1
- -1 guanidine compound Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2016255567 | 2016-12-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT3564230T true PT3564230T (pt) | 2022-05-19 |
Family
ID=62709416
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT178861092T PT3564230T (pt) | 2016-12-28 | 2017-12-27 | Compostos de guanidina substituídos |
Country Status (21)
Country | Link |
---|---|
US (2) | US11396514B2 (pt) |
EP (1) | EP3564230B1 (pt) |
JP (1) | JP7103228B2 (pt) |
KR (1) | KR102607007B1 (pt) |
CN (1) | CN110114350B (pt) |
AU (1) | AU2017385291B2 (pt) |
BR (1) | BR112019012020A8 (pt) |
CA (1) | CA3048854A1 (pt) |
CY (1) | CY1125090T1 (pt) |
DK (1) | DK3564230T3 (pt) |
ES (1) | ES2909133T3 (pt) |
HR (1) | HRP20220383T1 (pt) |
HU (1) | HUE058181T2 (pt) |
LT (1) | LT3564230T (pt) |
MX (1) | MX2019007786A (pt) |
PL (1) | PL3564230T3 (pt) |
PT (1) | PT3564230T (pt) |
RS (1) | RS63103B1 (pt) |
RU (1) | RU2757279C2 (pt) |
SI (1) | SI3564230T1 (pt) |
WO (1) | WO2018124179A1 (pt) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020083264A1 (zh) * | 2018-10-22 | 2020-04-30 | 广东东阳光药业有限公司 | 胍类衍生物及其用途 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2324922T3 (es) * | 2004-07-27 | 2009-08-19 | Astellas Pharma Inc. | Derivados de tiazol que tienen actividad inhibidora de vap-1. |
TWI490214B (zh) * | 2008-05-30 | 2015-07-01 | 艾德克 上野股份有限公司 | 苯或噻吩衍生物及該等作為vap-1抑制劑之用途 |
WO2010149684A1 (en) | 2009-06-24 | 2010-12-29 | Boehringer Ingelheim International Gmbh | New compounds, pharmaceutical composition and methods relating thereto |
RU2012114846A (ru) | 2009-09-16 | 2013-10-27 | Астеллас Фарма Инк. | Соединение глицина |
HUE034860T2 (en) * | 2011-03-15 | 2018-03-28 | Astellas Pharma Inc | Guanidine compound |
US10759781B2 (en) | 2015-08-06 | 2020-09-01 | Ube Industries, Ltd. | Substituted guanidine derivatives |
-
2017
- 2017-12-27 CA CA3048854A patent/CA3048854A1/en active Pending
- 2017-12-27 PT PT178861092T patent/PT3564230T/pt unknown
- 2017-12-27 US US16/474,339 patent/US11396514B2/en active Active
- 2017-12-27 DK DK17886109.2T patent/DK3564230T3/da active
- 2017-12-27 RS RS20220303A patent/RS63103B1/sr unknown
- 2017-12-27 WO PCT/JP2017/046898 patent/WO2018124179A1/ja unknown
- 2017-12-27 MX MX2019007786A patent/MX2019007786A/es unknown
- 2017-12-27 HR HRP20220383TT patent/HRP20220383T1/hr unknown
- 2017-12-27 CN CN201780081296.6A patent/CN110114350B/zh active Active
- 2017-12-27 RU RU2019123574A patent/RU2757279C2/ru active
- 2017-12-27 BR BR112019012020A patent/BR112019012020A8/pt active Search and Examination
- 2017-12-27 HU HUE17886109A patent/HUE058181T2/hu unknown
- 2017-12-27 LT LTEPPCT/JP2017/046898T patent/LT3564230T/lt unknown
- 2017-12-27 KR KR1020197021726A patent/KR102607007B1/ko active Active
- 2017-12-27 ES ES17886109T patent/ES2909133T3/es active Active
- 2017-12-27 EP EP17886109.2A patent/EP3564230B1/en active Active
- 2017-12-27 PL PL17886109T patent/PL3564230T3/pl unknown
- 2017-12-27 AU AU2017385291A patent/AU2017385291B2/en active Active
- 2017-12-27 JP JP2018559577A patent/JP7103228B2/ja active Active
- 2017-12-27 SI SI201731125T patent/SI3564230T1/sl unknown
-
2022
- 2022-03-29 CY CY20221100242T patent/CY1125090T1/el unknown
- 2022-06-16 US US17/841,815 patent/US11814393B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
HUE058181T2 (hu) | 2022-07-28 |
EP3564230A4 (en) | 2020-06-03 |
CN110114350A (zh) | 2019-08-09 |
KR20190097251A (ko) | 2019-08-20 |
EP3564230A1 (en) | 2019-11-06 |
US11396514B2 (en) | 2022-07-26 |
MX2019007786A (es) | 2019-08-16 |
RU2757279C2 (ru) | 2021-10-12 |
SI3564230T1 (sl) | 2022-05-31 |
BR112019012020A8 (pt) | 2023-01-17 |
RU2019123574A (ru) | 2021-01-29 |
AU2017385291B2 (en) | 2021-02-11 |
LT3564230T (lt) | 2022-04-11 |
US11814393B2 (en) | 2023-11-14 |
PL3564230T3 (pl) | 2022-05-09 |
RS63103B1 (sr) | 2022-04-29 |
US20220315599A1 (en) | 2022-10-06 |
DK3564230T3 (da) | 2022-03-28 |
KR102607007B1 (ko) | 2023-11-29 |
WO2018124179A1 (ja) | 2018-07-05 |
BR112019012020A2 (pt) | 2019-10-29 |
CN110114350B (zh) | 2022-03-04 |
JPWO2018124179A1 (ja) | 2019-10-31 |
CA3048854A1 (en) | 2018-07-05 |
JP7103228B2 (ja) | 2022-07-20 |
RU2019123574A3 (pt) | 2021-03-25 |
AU2017385291A1 (en) | 2019-07-18 |
HRP20220383T1 (hr) | 2022-05-13 |
US20190337962A1 (en) | 2019-11-07 |
ES2909133T3 (es) | 2022-05-05 |
CY1125090T1 (el) | 2024-02-16 |
EP3564230B1 (en) | 2022-02-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG11201802832UA (en) | Pyrimidine compound | |
GB2569389B (en) | Compound | |
GB2569388B (en) | Compound | |
IL258952B (en) | A pyranodipyridine compound | |
GB201721178D0 (en) | Compound | |
GB201721179D0 (en) | Compound | |
GB201521524D0 (en) | Compound | |
GB201721180D0 (en) | Compound | |
GB201721172D0 (en) | Compound | |
GB201617103D0 (en) | Compound | |
SI3630729T1 (sl) | Pirimidinska spojina | |
GB201612652D0 (en) | Novel compound | |
GB201609083D0 (en) | Synthetic compound | |
IL268060B (en) | Phenyldifluoromethyl-substituted prolinamide compound | |
RS63103B1 (sr) | Supstituisana jedinjenja gvanidina | |
GB201721673D0 (en) | Compound | |
PL3260289T3 (pl) | Element kompozytowy | |
GB201709565D0 (en) | Compound | |
GB201610497D0 (en) | Compound | |
GB201518950D0 (en) | Compound | |
GB201721324D0 (en) | Compound | |
ZA201801098B (en) | Tetrahydrooxepinopyridine compound | |
GB201703274D0 (en) | Compound | |
GB201619531D0 (en) | Compound | |
GB201619526D0 (en) | Compound |